Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients With Non-Small Cell Lung Cancer From Patients With Nonmalignant Lung Disease

Cancer Research - United States
doi 10.1158/0008-5472.can-09-1378
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Quantitative P16 and ESR1 Methylation in the Peripheral Blood of Patients With Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
1994English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Neural-Cadherin Expression Associated With Angiogenesis in Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2003English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Detection and Significance of TregFoxP3+ and Th17 Cells in Peripheral Blood of Non-Small Cell Lung Cancer Patients

Archives of Medical Science
Medicine
2014English

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-Small Cell Lung Cancer

Frontiers in Immunology
AllergyImmunology
2020English

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy